6 August, 2025Pi-Cardia’s ShortCut™ becomes First Leaflet Modification Technology to receive CMS NTAP for Valve-in-Valve TAVR
5 August, 2025Purespring Therapeutics receives UK CTA approval for Phase I/II clinical trial of PS-002 in patients with primary IgA nephropathy (IgAN)
30 July, 2025Nuage Therapeutics welcomes Olivier Corminboeuf and Blandine Guimet to their Leadership Team
23 July, 2025TISSIUM announces U.S. commercial launch of COAPTIUM® Connect and strategic governance evolution